CD40 activation induces NREM sleep and modulates genes associated with sleep homeostasis

Brain Behav Immun. 2013 Jan;27(1):133-44. doi: 10.1016/j.bbi.2012.10.004. Epub 2012 Oct 13.

Abstract

The T-cell derived cytokine CD40 ligand is overexpressed in patients with autoimmune diseases. Through activation of its receptor, CD40 ligand leads to a tumor necrosis factor (TNF) receptor 1 (TNFR1) dependent impairment of locomotor activity in mice. Here we report that this effect is explained through a promotion of sleep, which was specific to non-rapid eye movement (NREM) sleep while REM sleep was suppressed. The increase in NREM sleep was accompanied by a decrease in EEG delta power during NREM sleep and by a decrease in the expression of transcripts in the cerebral cortex known to be associated with homeostatic sleep drive, such as Homer1a, Early growth response 2, Neuronal pentraxin 2, and Fos-like antigen 2. The effect of CD40 activation was mimicked by peripheral TNF injection and prevented by the TNF blocker etanercept. Our study indicates that sleep-wake dysregulation in autoimmune diseases may result from CD40 induced TNF:TNFR1 mediated alterations of molecular pathways, which regulate sleep-wake behavior.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / metabolism
  • Brain* / drug effects
  • Brain* / metabolism
  • C-Reactive Protein / drug effects
  • C-Reactive Protein / genetics
  • C-Reactive Protein / metabolism
  • CD40 Antigens / agonists
  • CD40 Antigens / metabolism*
  • Carrier Proteins / drug effects
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Early Growth Response Protein 2 / drug effects
  • Early Growth Response Protein 2 / genetics
  • Early Growth Response Protein 2 / metabolism
  • Electroencephalography / drug effects
  • Electromyography
  • Etanercept
  • Fos-Related Antigen-2 / drug effects
  • Fos-Related Antigen-2 / genetics
  • Fos-Related Antigen-2 / metabolism
  • Homer Scaffolding Proteins
  • Immunoglobulin G / pharmacology
  • Immunologic Factors / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I / drug effects
  • Receptors, Tumor Necrosis Factor, Type I / metabolism
  • Sleep / drug effects
  • Sleep / physiology*
  • Sleep Disorders, Circadian Rhythm / complications
  • Sleep Disorders, Circadian Rhythm / metabolism
  • Sleep, REM / drug effects
  • Sleep, REM / physiology
  • Tumor Necrosis Factor-alpha* / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha* / drug effects
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Antibodies, Monoclonal
  • CD40 Antigens
  • Carrier Proteins
  • Early Growth Response Protein 2
  • Egr2 protein, mouse
  • Fos-Related Antigen-2
  • Fosl2 protein, mouse
  • Homer Scaffolding Proteins
  • Immunoglobulin G
  • Immunologic Factors
  • Nerve Tissue Proteins
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • Tnfrsf1a protein, mouse
  • Tumor Necrosis Factor-alpha
  • neuronal pentraxin
  • C-Reactive Protein
  • Etanercept